FRANCO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.866
AS - Asia 1.383
EU - Europa 1.043
SA - Sud America 187
AF - Africa 96
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.584
Nazione #
US - Stati Uniti d'America 1.804
CN - Cina 488
SG - Singapore 355
IE - Irlanda 264
VN - Vietnam 215
HK - Hong Kong 168
RU - Federazione Russa 166
BR - Brasile 134
IT - Italia 125
DE - Germania 116
FI - Finlandia 104
ZA - Sudafrica 70
FR - Francia 66
GB - Regno Unito 48
UA - Ucraina 34
IN - India 31
CA - Canada 30
BD - Bangladesh 26
CZ - Repubblica Ceca 21
MX - Messico 20
BE - Belgio 18
SE - Svezia 16
AR - Argentina 14
NL - Olanda 12
CO - Colombia 11
IQ - Iraq 11
JP - Giappone 11
PL - Polonia 11
TR - Turchia 11
ES - Italia 9
PK - Pakistan 9
AT - Austria 8
AU - Australia 8
EC - Ecuador 8
LT - Lituania 7
PH - Filippine 7
UZ - Uzbekistan 7
PE - Perù 6
IL - Israele 5
MA - Marocco 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
MU - Mauritius 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
JO - Giordania 3
KG - Kirghizistan 3
KR - Corea 3
CG - Congo 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
HR - Croazia 2
ID - Indonesia 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
PA - Panama 2
PY - Paraguay 2
SI - Slovenia 2
TH - Thailandia 2
TJ - Tagikistan 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GN - Guinea 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
NE - Niger 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 4.584
Città #
Dublin 264
San Jose 246
Ashburn 239
Chandler 204
Singapore 201
Hong Kong 159
Beijing 147
Dallas 121
Boardman 91
Ho Chi Minh City 70
Johannesburg 66
Helsinki 53
Ann Arbor 52
Los Angeles 52
Hanoi 49
Lauterbourg 49
Munich 46
Jacksonville 43
Nanjing 41
Princeton 41
Lawrence 40
New York 38
Moscow 34
Medford 30
Shanghai 30
Turku 27
Council Bluffs 26
Redondo Beach 26
Wilmington 26
Hebei 24
Changsha 22
Buffalo 20
Milan 20
Nanchang 18
Brussels 17
São Paulo 17
Brno 16
Orem 16
Pavia 16
Woodbridge 15
Brooklyn 13
Frankfurt am Main 13
Piscataway 13
The Dalles 13
Toronto 13
Chicago 12
Shenyang 12
Da Nang 11
Phoenix 11
Tokyo 11
Warsaw 11
Houston 10
Jiaxing 10
Montreal 10
Rome 10
Mexico City 9
Seattle 9
Atlanta 8
Santa Clara 8
Tianjin 8
Baghdad 7
Boston 7
Nuremberg 7
San Francisco 7
Stockholm 7
Chennai 6
Denver 6
Guangzhou 6
Haiphong 6
Hangzhou 6
Istanbul 6
Rio de Janeiro 6
Biên Hòa 5
Brasília 5
Campinas 5
Columbus 5
Dhaka 5
Florence 5
Manchester 5
Medellín 5
Mumbai 5
Nha Trang 5
Norwalk 5
Poplar 5
Tashkent 5
Turin 5
Washington 5
Wuhan 5
Amsterdam 4
Bắc Ninh 4
Curitiba 4
Fairfield 4
Falkenstein 4
Giv‘atayim 4
Guarulhos 4
Lima 4
London 4
Melbourne 4
Nairobi 4
Quận Ba 4
Totale 3.132
Nome #
A simple and rapid HPLC-UV method for the determination of retigabine in human plasma 169
A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma 163
Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. 155
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. on behalf of the SOPHIE Study Group. 131
Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. 131
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. 127
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring 115
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 115
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe 114
Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease 113
2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors 108
Development and validation of an HPLC-UV assay for the therapeutic monitoring of the new antiepileptic drug perampanel in human plasma 107
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 106
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine 99
Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine 96
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 95
Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy 94
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy 94
Novel treatment options for epilepsy: Focus on perampanel 93
Challenges in the clinical development of new antiepileptic drugs 93
Antiepileptic drugs and brain maturation: Fetal exposure to lamotrigine generates cortical malformations in rats. 93
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects 93
Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique 92
Fate of melatonin orally administered in preterm newborns: Antioxidant performance and basis for neuroprotection 92
Analysis of nocebo effects of antiepileptic drugs across different conditions 92
Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies 91
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy 91
Author Response: Does Screening for Adverse Effects Improve Health Outcomes in Epilepsy? A Randomized Trial 86
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research 83
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 83
Melatonin versus Sleep Deprivation for Sleep Induction in Nap Electroencephalography: Protocol for a Prospective Randomized Crossover Trial in Children and Young Adults with Epilepsy 83
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 80
Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats 80
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 76
The pharmacogenomics of epilepsy 75
Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy 74
On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva 73
Zonisamide in the management of epilepsy in the elderly 65
Profile of pitolisant in the management of narcolepsy: Design, development, and place in therapy 59
Straightforward access to 2,3- and 3,4-unsaturated derivatives of N-glycolylneuraminic acid 55
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 54
The adverse event profile of levetiracetam: A meta-analysis on children and adults 54
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures 54
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations 54
Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies 51
Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy 50
Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring 45
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 45
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy 44
Tolerability of new antiepileptic drugs: a network meta-analysis 43
Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 42
Pharmacokinetic Interactions Between Antiseizure and Psychiatric Medications 37
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 36
Automated Workflow for High-Throughput LC–MS/MS Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Patients with Epilepsy 36
Solubility of lamotrigine in age-specific biorelevant media that simulated the fasted- and fed-conditions of the gastric and intestinal environments in pediatrics and adults: implications for traditional, re-formulated, modified, and new oral formulations 36
Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study 31
The effects of daylight saving time and clock time transitions on sleep and sleepiness: a systematic review 28
Early Oral Melatonin Supplementation Supports White Matter Maturation in Preterm Infants: Neuroprotective Insights of an Antioxidant Molecule 7
Totale 4.681
Categoria #
all - tutte 21.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.283


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022171 2 2 7 2 2 1 2 7 11 5 32 98
2022/2023640 80 62 5 35 54 44 0 36 288 7 21 8
2023/2024301 49 24 14 23 28 67 14 32 2 9 26 13
2024/2025894 41 55 19 17 19 75 57 41 237 33 113 187
2025/20262.201 155 135 208 202 290 86 426 160 217 141 112 69
Totale 4.681